Publications by authors named "Yuki Enoki"

Claim this Profile
D
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patients.
Toshiaki Komatsu, Atsushi Tomizawa, Masaru Samura, Ayako Suzuki, Tomoyuki Ishigo, Yuki Enoki

J Infect Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of epithelial lining fluid drug concentrations to MIC-Based PK/PD modeling of cefepime/nacubactam in a murine model of CPE pneumonia.
Yuki Mizukami, Mishu Takahashi, Kenta Suzuki, Shaoqing Duan, Shintaro Ikegami, Yuki Enoki

J Infect Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral β-lactam combinations are effective against , regardless of clarithromycin susceptibility.
Maiko Yoshikawa, Tomoyasu Nishimura, Kana Misawa, Rina Shimamura, Kenta Suzuki, Yuki Enoki

Microbiol Spectr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring.
Ayako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, Hiroaki Yoshida, Hiroaki Tanaka, Yuki Enoki

J Infect Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of treatment success in patients with Enterococcus faecium bacteremia using vancomycin AUC/MIC ratio: A multicenter retrospective study.
Yuki Hanai, Kazuaki Matsumoto, Kazumi Hanawa, Aiju Endo, Hideki Hashi, Yuki Enoki

Diagn Microbiol Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CKD-Induced Oxidative Twitch Muscle Atrophy Is Mediated by TGF- β.
Kyoka Homma, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto

Kidney360· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Yuki Enoki

J Pharm Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials.
Ayano Kawasaki, Ryuya Shintani, Risa Takao, Yuka Nakazawa, Takayuki Mihara, Yuki Enoki

Med Mycol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and validation of downsized hollow-fibre infection model and pharmacokinetics/pharmacodynamics analysis of VAN on Enterococcus faecium.
Yukitaka Hayashi, Mishu Takahashi, Moe Sasaki, Kenta Suzuki, Yuki Mizukami, Yuki Enoki

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro.
Kana Misawa, Tomoyasu Nishimura, Maiko Yoshikawa, Rina Shimamura, Shoko Kashimura, Yuki Enoki

J Glob Antimicrob Resist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a flowchart related to achieving the target area under the concentration-time curve for vancomycin: A retrospective multicenter study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Yuki Enoki

J Infect Chemother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortening the interval between the first and the second dose of vancomycin facilitates rapid achievement of the target AUC without increasing the risk of acute kidney injury, provided the AUC on the second day is appropriately controlled: a multicenter retrospective study.
Tomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Yuki Enoki

J Pharm Health Care Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence factors of metronidazole-related CNS disorders: an analysis of the Japan adverse drug event report and FDA adverse event reporting system.
Keisuke Takada, Yuki Enoki, Masaru Samura, Yuki Igarashi, Kazuaki Taguchi

Expert Opin Drug Saf· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon monoxide alleviates endotoxin-induced acute lung injury via NADPH oxidase inhibition in macrophages and neutrophils.
Yuki Watabe, Victor Tuan Giam Chuang, Hiromi Sakai, Chihiro Ito, Yuki Enoki

Biochem Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors".
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe, Yuki Enoki

Microbiol Spectr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age.
Keisuke Takada, Masaru Samura, Yuki Igarashi, Ayako Suzuki, Tomoyuki Ishigo, Yuki Enoki

J Pharm Health Care Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a pharmacokinetic/pharmacodynamic evaluation model for osteomyelitis and usefulness of tedizolid as an alternative to vancomycin against MRSA osteomyelitis.
Xiaoxi Liu, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto

J Pharm Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysis.
Yuki Igarashi, Kazuaki Taguchi, Yuki Enoki, Victor Tuan Giam Chuang, Kazuaki Matsumoto

J Antimicrob Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study.
Yuki Hanai, Kazuaki Matsumoto, Aiju Endo, Kazumi Hanawa, Hideki Hashi, Yuki Enoki

J Antimicrob Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database.
Keisuke Takada, Kazuaki Taguchi, Masaru Samura, Yuki Igarashi, Yuko Okamoto, Yuki Enoki

J Infect Chemother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrosulphide-methaemoglobin-albumin cluster: a hydrogen sulphide donor.
Yuto Suzuki, Taiga Yamada, Yuki Enoki, Kazuaki Matsumoto, Teruyuki Komatsu

J Mater Chem B· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation.
Ayako Suzuki, Masaru Samura, Tomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, Yuki Enoki

Pharm Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the hypothermic effects of fluoroquinolone antimicrobials on non-bacterial fever model mice.
Ryohei Hara, Kazuaki Taguchi, Hiromi Ogino, Yuko Okamoto, Yuki Enoki

J Pharm Health Care Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell immunosuppression in sepsis is augmented by sciatic denervation-induced skeletal muscle atrophy.
Sumika Osa, Yuki Enoki, Daisuke Takahashi, Victor Tuan Giam Chuang, Kazuaki Taguchi

FEBS Lett· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Stewardship of Oral Third-Generation Cephalosporins in Community Pharmacy: A Single-Center Quasi-Experimental Study.
Koyo Nakamura, Kazuaki Matsumoto, Yuki Enoki, Kazuaki Taguchi, Shuji Yamashita

Biol Pharm Bull· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis